{"id":"https://openalex.org/W2140887733","doi":"https://doi.org/10.1093/jnci/94.8.545","title":"COX-2 in Cancer--A Player That's Defining the Rules","display_name":"COX-2 in Cancer--A Player That's Defining the Rules","publication_year":2002,"publication_date":"2002-04-17","ids":{"openalex":"https://openalex.org/W2140887733","doi":"https://doi.org/10.1093/jnci/94.8.545","mag":"2140887733","pmid":"https://pubmed.ncbi.nlm.nih.gov/11959883"},"language":"en","primary_location":{"id":"doi:10.1093/jnci/94.8.545","doi":"https://doi.org/10.1093/jnci/94.8.545","is_oa":false,"landing_page_url":"https://doi.org/10.1093/jnci/94.8.545","pdf_url":null,"source":{"id":"https://openalex.org/S98010888","display_name":"JNCI Journal of the National Cancer Institute","issn_l":"0027-8874","issn":["0027-8874","1460-2105"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"CancerSpectrum Knowledge Environment","raw_type":"journal-article"},"volume":null,"type":"editorial","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5015008352","display_name":"Ernest T. Hawk","orcid":"https://orcid.org/0000-0002-9062-7338","observed_orcids":["https://orcid.org/0000-0002-9062-7338"]},"institutions":[{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"E. T. Hawk","raw_affiliation_strings":["Correspondence to: Ernest T. Hawk, M.D., M.P.H., Chief, Gastrointestinal and Other Cancers Research Group, National Cancer Institute, Division of Cancer Prevention, EPN, Suite 2141, 6130 Executive Blvd., Bethesda, MD 20892\u20137317 (","Clinical Cancer Prevention"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Correspondence to: Ernest T. Hawk, M.D., M.P.H., Chief, Gastrointestinal and Other Cancers Research Group, National Cancer Institute, Division of Cancer Prevention, EPN, Suite 2141, 6130 Executive Blvd., Bethesda, MD 20892\u20137317 (","institution_ids":["https://openalex.org/I4210140884"]},{"raw_affiliation_string":"Clinical Cancer Prevention","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5015008352"],"corresponding_institution_ids":["https://openalex.org/I4210140884"],"apc_list":{"value":5436,"currency":"USD","value_usd":5436},"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":82,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"94","issue":"8","first_page":"545","last_page":"546"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10678","display_name":"Inflammatory mediators and NSAID effects","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10678","display_name":"Inflammatory mediators and NSAID effects","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12465","display_name":"Cancer, Lipids, and Metabolism","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12910","display_name":"Eicosanoids and Hypertension Pharmacology","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1303","display_name":"Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cyclooxygenase-2","display_name":"cyclooxygenase-2","score":0.9760000109672546},{"id":"https://openalex.org/keywords/cox-2-inhibitors","display_name":"COX-2 inhibitors","score":0.9010000228881836},{"id":"https://openalex.org/keywords/celecoxib","display_name":"celecoxib","score":0.8100000023841858},{"id":"https://openalex.org/keywords/rofecoxib","display_name":"rofecoxib","score":1.0},{"id":"https://openalex.org/keywords/cancer-prevention","display_name":"cancer prevention","score":0.5559999942779541},{"id":"https://openalex.org/keywords/colorectal-cancer","display_name":"colorectal cancer","score":0.7599999904632568},{"id":"https://openalex.org/keywords/colorectal-adenoma","display_name":"colorectal adenoma","score":0.7009999752044678},{"id":"https://openalex.org/keywords/prostaglandins","display_name":"prostaglandins","score":0.7799999713897705},{"id":"https://openalex.org/keywords/arachidonic-acid-metabolites","display_name":"arachidonic acid metabolites","score":0.9610000252723694},{"id":"https://openalex.org/keywords/tumor-suppression","display_name":"tumor suppression","score":0.42800000309944153},{"id":"https://openalex.org/keywords/cox-independent-mechanism","display_name":"COX-independent mechanism","score":0.7549999952316284},{"id":"https://openalex.org/keywords/inflammation-and-carcinogenesis","display_name":"inflammation and carcinogenesis","score":0.5580000281333923}],"concepts":[{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4900027811527252},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.3342035412788391},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3183237314224243},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.20811277627944946}],"mesh":[{"descriptor_ui":"D000068579","descriptor_name":"Celecoxib","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D002455","descriptor_name":"Cell Division","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007527","descriptor_name":"Isoenzymes","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D007527","descriptor_name":"Isoenzymes","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":true},{"descriptor_ui":"D008565","descriptor_name":"Membrane Proteins","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000201","qualifier_name":"enzymology","is_major_topic":true},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":false},{"descriptor_ui":"D011451","descriptor_name":"Prostaglandin-Endoperoxide Synthases","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D011451","descriptor_name":"Prostaglandin-Endoperoxide Synthases","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":true},{"descriptor_ui":"D011720","descriptor_name":"Pyrazoles","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013449","descriptor_name":"Sulfonamides","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D017209","descriptor_name":"Apoptosis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051546","descriptor_name":"Cyclooxygenase 2","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1093/jnci/94.8.545","doi":"https://doi.org/10.1093/jnci/94.8.545","is_oa":false,"landing_page_url":"https://doi.org/10.1093/jnci/94.8.545","pdf_url":null,"source":{"id":"https://openalex.org/S98010888","display_name":"JNCI Journal of the National Cancer Institute","issn_l":"0027-8874","issn":["0027-8874","1460-2105"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"CancerSpectrum Knowledge Environment","raw_type":"journal-article"},{"id":"pmid:11959883","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11959883","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of the National Cancer Institute","raw_type":"Comment"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.516.1299","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.516.1299","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"http://jnci.oxfordjournals.org/content/94/8/545.full.pdf","raw_type":"text"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":17,"referenced_works":["https://openalex.org/W1482218984","https://openalex.org/W1552442738","https://openalex.org/W1882144023","https://openalex.org/W2002876988","https://openalex.org/W2051686420","https://openalex.org/W2061424084","https://openalex.org/W2062861788","https://openalex.org/W2088905899","https://openalex.org/W2099902447","https://openalex.org/W2114237338","https://openalex.org/W2123274778","https://openalex.org/W2133125477","https://openalex.org/W2143296984","https://openalex.org/W2145149010","https://openalex.org/W2151324279","https://openalex.org/W2170717609","https://openalex.org/W2336169581"],"related_works":["https://openalex.org/W2184254794","https://openalex.org/W2064738453","https://openalex.org/W2049433363","https://openalex.org/W2054137985","https://openalex.org/W2412285949","https://openalex.org/W2041676299","https://openalex.org/W2094843254","https://openalex.org/W2303469300","https://openalex.org/W7099909083","https://openalex.org/W7100646679"],"abstract_inverted_index":{"Cyclooxygenase":[0],"(COX)":[1],"inhibitors":[2,64,108],"are":[3,216],"being":[4],"developed":[5,95],"as":[6,110,173],"potential":[7],"agents":[8,118],"for":[9,22,45,96,229],"the":[10,29,69,102,200,230],"prevention":[11],"and":[12,25,59,68,74,101,128,132,165,189],"treatment":[13,103],"of":[14,19,36,53,71,104,113,130,233],"cancer":[15],"after":[16],"a":[17,43,111,125],"century":[18],"widespread":[20],"use":[21],"inflammation,":[23],"fever,":[24],"pain.":[26],"Beginning":[27],"in":[28,38,49,56,98,124,139,157,204],"late":[30],"1970s,":[31],"researchers":[32],"noted":[33],"elevated":[34],"concentrations":[35],"prostaglandins":[37],"neoplastic":[39],"lesions,":[40],"which":[41],"suggested":[42],"role":[44],"arachidonic":[46],"acid":[47],"metabolites":[48],"tumorigenesis.":[50],"Multiple":[51],"lines":[52],"evidence\u2014in":[54],"vitro,":[55],"vivo,":[57],"observational,":[58],"clinical\u2014now":[60],"confirm":[61],"that":[62,89,147,215,220],"COX":[63,86,224],"reduce":[65,199],"prostaglandin":[66],"production":[67],"risk":[70],"colorectal,":[72],"skin,":[73],"other":[75,222],"neoplasias":[76],"(1).":[77],"Owing":[78],"to":[79,138,198],"gastrointestinal":[80],"safety":[81],"concerns":[82],"with":[83],"traditional":[84],"nonselective":[85],"inhibitors,":[87,171],"derivatives":[88],"selectively":[90],"target":[91],"COX-2":[92,106,120,154,170],"have":[93,211],"been":[94,196],"applications":[97],"arthritis,":[99],"analgesia,":[100],"neoplasia.":[105],"selective":[107,169],"serve":[109],"paradigm":[112],"molecularly":[114],"targeted,":[115],"cytostatic,":[116],"antineoplastic":[117],"(2).":[119],"is":[121],"consistently":[122],"overexpressed":[123],"large":[126],"percentage":[127],"variety":[129],"human":[131],"rodent":[133],"tumors":[134],"(3).":[135],"Pathogenic":[136],"relevance":[137],"vivo":[140],"carcinogenesis":[141],"was":[142],"demonstrated":[143],"via":[144],"genetic":[145],"manipulations":[146],"either":[148],"eliminated":[149],"(4)":[150],"or":[151,161,179],"induced":[152],"(5)":[153],"expression,":[155],"resulting":[156],"substantial":[158],"tumor":[159],"reduction":[160],"stimulation,":[162],"respectively.":[163],"Food":[164],"Drug":[166],"Administration":[167],"(FDA)-approved":[168],"such":[172],"celecoxib":[174,193],"(Celebrex\u2122;":[175],"Pharmacia,":[176],"Peapack,":[177],"NJ)":[178],"rofecoxib":[180],"(Vioxx\u2122;":[181],"Merck,":[182],"Whitehouse":[183],"Station,":[184],"NJ),":[185],"effectively":[186],"modulate":[187],"inflammation":[188],"pain":[190],"(6).":[191],"Moreover,":[192],"has":[194],"recently":[195],"shown":[197],"colorectal":[201],"adenoma":[202],"burden":[203],"high-risk":[205],"patients":[206],"(7).":[207],"Cancer":[208],"researchers,":[209],"however,":[210],"reported":[212],"COX-independent":[213],"effects":[214],"dose":[217],"dependent,":[218],"suggesting":[219],"mechanisms":[221],"than":[223],"suppression":[225],"alone":[226],"may":[227],"account":[228],"observed":[231],"efficacy":[232],"these":[234],"agents.":[235]},"counts_by_year":[{"year":2025,"cited_by_count":2},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":4},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":5},{"year":2015,"cited_by_count":3},{"year":2014,"cited_by_count":5},{"year":2013,"cited_by_count":3},{"year":2012,"cited_by_count":4}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}